These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11008656)

  • 1. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro.
    Nery JA; Sampaio EP; Galhardo MC; Perissé AR; Vieira LM; Salles AM; Sarno EN
    Indian J Lepr; 2000; 72(2):155-67. PubMed ID: 11008656
    [No Abstract]   [Full Text] [Related]  

  • 2. Leprosy and HIV, where are we at?
    Lockwood DN; Lambert SM
    Lepr Rev; 2010 Sep; 81(3):169-75. PubMed ID: 21067057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells.
    Massone C; Talhari C; Talhari S; Brunasso AM; Campbell TM; Curcic P; Cerroni L; Ribeiro-Rodrigues R
    Br J Dermatol; 2011 Aug; 165(2):321-8. PubMed ID: 21574977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Players in the Same Old Game: Disturbance of Group 2 Innate Lymphoid Cells in HIV-1 and Mycobacterium leprae Co-infected Patients.
    Papotto PH; Maeda S; Tomimori J; Xavier MB; Rizzo LV; Kallas EG; Carvalho KI
    PLoS Negl Trop Dis; 2015; 9(9):e0004030. PubMed ID: 26335023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort.
    Pereira GA; Stefani MM; Araújo Filho JA; Souza LC; Stefani GP; Martelli CM
    Am J Trop Med Hyg; 2004 Nov; 71(5):679-84. PubMed ID: 15569804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.
    Batista MD; Porro AM; Maeda SM; Gomes EE; Yoshioka MC; Enokihara MM; Tomimori J
    Clin Infect Dis; 2008 Mar; 46(6):e56-60. PubMed ID: 18269334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
    Sampaio EP; Caneshi JR; Nery JA; Duppre NC; Pereira GM; Vieira LM; Moreira AL; Kaplan G; Sarno EN
    Infect Immun; 1995 May; 63(5):1848-54. PubMed ID: 7729894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E; De Boer T; Zulianello L; Ottenhoff TH
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18.
    Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM
    Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T; Myklestad B; Samuel DR; Myrvang B
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome.
    Trindade MA; Valente NY; Manini MI; Takahashi MD; Anjos CF; Benard G; Naafs B
    J Clin Microbiol; 2006 Dec; 44(12):4616-8. PubMed ID: 17021066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does concomitant hiv infection has any epidemiological, clinical, immunopathological and therapeutic relevance in leprosy?
    Kar HK; Sharma P
    Indian J Lepr; 2007; 79(1):45-60. PubMed ID: 17578267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.
    Carvalho KI; Bruno FR; Snyder-Cappione JE; Maeda SM; Tomimori J; Xavier MB; Haslett PA; Nixon DF; Kallas EG
    Immunology; 2012 May; 136(1):96-102. PubMed ID: 22269018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.
    Carvalho KI; Maeda S; Marti L; Yamashita J; Haslett PA; Kallas EG
    Immunology; 2008 Jun; 124(2):206-14. PubMed ID: 18284466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and leprosy in the Eastern United States.
    Lu PD; Patel MJ; Yosipovitch G; Martiniuk F; Cabrera A; Levis WR
    J Infect Dis; 2005 Nov; 192(9):1673-4; author reply 1674-5. PubMed ID: 16206087
    [No Abstract]   [Full Text] [Related]  

  • 17. Some possible interactions of M. leprae and HIV in the peripheral nerves.
    Patki AH
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):331-2. PubMed ID: 1649237
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective loss of Mycobacterium leprae responsiveness of circulating lymphocytes in primary neuritic leprosy.
    Nath I; Narayanan RB; Sathish M; Ahuja GK; Bhutani LK; Singh R
    Lepr Rev; 1981 Mar; 52(1):79-89. PubMed ID: 7017320
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of clinical, histological and immunological features across the leprosy spectrum.
    Narayan NP; Ramu G; Desikan KV; Vallishayee RS
    Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):300-7. PubMed ID: 4948077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.